Osteoporosi (anno 27°)
Raccolta bibliografica PubMed a cura di C.Tarozzi  (ottobre 2022)
Scelte bibliografiche compilate nel mese di agosto-2022. Numero di lavori trovati 16
Kobayakawa T, Miyazaki A, Takahashi J, Nakamura Y.
Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment withromosozumab as sequential therapy: The prospective VICTOR study.
Bone. 2022 Sep;162:116480.
Makras P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, Winter EM, Polyzos SA, Yavropoulou MP, Anastasilakis AD.
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation.
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4155-e4162.
Iuliano S, Poon S, Robbins J, Bui M, Wang X, De Groot L, Van Loan M, Zadeh AG, Nguyen T, Seeman E.
Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care: cluster randomised controlled trial.
BMJ. 2021 Oct 20;375:n2364.
Hirooka Y, Nozaki Y, Okuda S, Sugiyama M, Kinoshita K, Funauchi M, Matsumura I.
Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment.
Front Endocrinol (Lausanne). 2021 Sep 27;12:753185.
Ryhänen EM, Koski AM, Löyttyniemi E, Välimäki MJ, Kiviniemi U, Schalin-Jäntti C.
Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study.
Eur J Endocrinol. 2021 Aug 27;185(4):515-524.
Hagino H, Sugimoto T, Tanaka S, Sasaki K, Sone T, Nakamura T, Soen S, Mori S.
A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
Osteoporos Int. 2021 Nov;32(11):2301-2311.
Makras P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, Winter EM, Polyzos SA, Yavropoulou MP, Anastasilakis AD.
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation.
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4155-e4162.
Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG)
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Lancet. 2021 Nov 27;398(10315):1984-1996.
Kistler-Fischbacher M, Yong JS, Weeks BK, Beck BR.
A Comparison of Bone-Targeted Exercise With and Without Antiresorptive Bone Medication to Reduce Indices of Fracture Risk in Postmenopausal Women With Low Bone Mass: The MEDEX-OP Randomized Controlled Trial.
J Bone Miner Res. 2021 Sep;36(9):1680-1693.
Cornelissen D, Boonen A, Evers S, van den Bergh JP, Bours S, Wyers CE, van Kuijk S, van Oostwaard M, van der Weijden T, Hiligsmann M.
Improvement of osteoporosis Care Organized by Nurses: ICON study - Protocol of a quasi-experimental study to assess the cost effectiveness of combining a decision aid with motivational interviewing for improving medication persistence in patients with a recent fracture being treated at the fracture liaison service.
BMC Musculoskelet Disord. 2021 Oct 29;22(1):913.
Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C.
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
J Bone Miner Res. 2021 Nov;36(11):2139-2152.
Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, Liu S, Looker AC, Wallace TC, Wang DD.
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
Osteoporos Int. 2016 Jan;27(1):367-76.
Liu C , Kuang X , Li K , Guo X , Deng Q , Li D .
Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Food Funct. 2020 Dec 1;11(12):10817-10827.
Reid IR, Bolland MJ, Grey A.
Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis.
Lancet. 2014 Jan 11;383(9912):146-55.
Avenell A, Mak JC, O'Connell D.
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Cochrane Database Syst Rev. 2014 Apr 14;2014(4):CD000227
Reyes-Garcia R, Mendoza N, Palacios S, Salas N, Quesada-Charneco M, Garcia-Martin A, Fonolla J, Lara-Villoslada F, Muñoz-Torres M.
Effects of Daily Intake of Calcium and Vitamin D-Enriched Milk in Healthy Postmenopausal Women: A Randomized, Controlled, Double-Blind Nutritional Study.
J Womens Health (Larchmt). 2018 May;27(5):561-568.